Tetralogic Pharmaceuticals Corp (TLOG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,724 | -35,959 | -19,950 | -16,200 | -18,920 |
| Depreciation Amortization | 17,091 | 126 | 100 | 154 | 215 |
| Other Working Capital | 1,082 | -2,813 | 1,413 | -231 | 1,055 |
| Other Operating Activity | -3,338 | 6,279 | 5,669 | 349 | 318 |
| Operating Cash Flow | $-34,889 | $-32,366 | $-12,769 | $-15,928 | $-17,333 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,525 | -40,633 | N/A | 5,526 | -5,526 |
| PPE Investments | -77 | -515 | -67 | -29 | -14 |
| Net Acquisitions | N/A | -12,848 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 20 | 0 | 0 | 0 |
| Investing Cash Flow | $35,448 | $-53,975 | $-67 | $5,497 | $-5,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 44,147 | 14,235 | 4,969 | N/A |
| Debt Repayment | -825 | N/A | N/A | -34 | -142 |
| Common Stock Issued | 2,615 | 201 | 49,225 | 2 | 15 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 7,249 |
| Financing Cash Flow | $1,790 | $44,348 | $63,460 | $4,936 | $7,122 |
| Exchange Rate Effect | -119 | -69 | N/A | N/A | N/A |
| Beginning Cash Position | 13,073 | 55,136 | 4,512 | 10,006 | 25,756 |
| End Cash Position | 15,302 | 13,073 | 55,136 | 4,512 | 10,006 |
| Net Cash Flow | $2,229 | $-42,062 | $50,624 | $-5,494 | $-15,750 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,889 | -32,366 | -12,769 | -15,928 | -17,333 |
| Capital Expenditure | -77 | -515 | -67 | -29 | -14 |
| Free Cash Flow | -34,967 | -32,881 | -12,836 | -15,957 | -17,346 |